Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- Nature Careers
- The University of Arizona
- Fred Hutchinson Cancer Center
- Baylor College of Medicine
- Stanford University
- THE UNIVERSITY OF HONG KONG
- University of North Carolina at Chapel Hill
- Aarhus University
- Argonne
- Forschungszentrum Jülich
- MOHAMMED VI POLYTECHNIC UNIVERSITY
- Technical University of Denmark
- University of Oxford
- Cornell University
- ICN2
- INSERM
- National Hellenic Research Foundation
- Texas A&M AgriLife
- UNIVERSITY OF SYDNEY
- University of Southern California
- University of Tübingen
- University of Virginia
- Virginia Tech
- Washington State University
- Angelo State University
- BENAJIBA team - INSERM U1342 - Saint-Louis Research Institute
- Brookhaven Lab
- Central State University
- Delft University of Technology (TU Delft); yesterday published
- Durham University
- ETH Zürich
- Eindhoven University of Technology (TU/e)
- Eindhoven University of Technology (TU/e); yesterday published
- Emory University
- Gustave Roussy Cancer Campus
- Inria, the French national research institute for the digital sciences
- Institut Pasteur
- KINGS COLLEGE LONDON
- Karolinska Institutet (KI)
- Laboratoire d'Astrophysique de Marseille
- Leibniz
- Medical College of Wisconsin
- New York University
- Northeastern University
- RCSI - Royal College of Surgeons in Ireland
- Rice University
- The Ohio State University
- Universidade de Coimbra
- University of Amsterdam (UvA); yesterday published
- University of Colorado
- University of Florida
- University of Gdańsk, Intercollegiate Faculty of Biotechnology
- University of Lille
- University of Lund
- University of Luxembourg
- University of Massachusetts Boston
- University of Miami
- University of Minnesota
- University of South Carolina
- University of Southern California (USC)
- University of Southern Denmark
- University of Sydney
- University of Utah
- University of Washington
- Université de Bordeaux / University of Bordeaux
- Wayne State University
- Yale University
- Łukasiewicz Research Network - Krakow Institute of Technology
- 58 more »
- « less
-
Field
-
scientific track record demonstrating well-organized design and execution of studies. Experience with various deep etching techniques (e.g., wet etching, RIE). Experience with soft lithography. Experience with
-
components: Deep learning and LLMs for molecular biology Multi-omics datasets (e.g., TCGA, TARGET, CCLE) Single-cell and spatial transcriptomics/proteomics High-throughput drug and genetic screens (e.g
-
to assess the potential of the new iteration(s) of the microphysiological platform for targeted biomedical purposes. Present results at laboratory meetings and conferences. Keep track of the current
-
suited to a Postdoctoral Researcher who has established expertise and track record in cardiovascular disease, and could benefit from support of the BHF’s award to develop their career and make major
-
- Development of a novel therapeutic strategy for targeting intracellular antigens in triple-negative breast cancer using self-immolative hyaluronic acid-antibody conjugates”. The call is governed by this Notice
-
navigation paradigms, targeted gene perturbation, or single-cell transcriptomic assays. They will participate in project conception, data acquisition, analyses, and dissemination of the work. They will have
-
morphology, physiology, and growth characteristics of embryos, to identify genes and traits that can be targeted for future clinical therapies Develop and manage databases to store and organize multiomics data
-
for structural biology and other applications (ligand binding, enzymatic activity etc.). Involvement in the research pertinent to specific protein targets will be expected as well, along with presentation
-
About the opportunity The Cancer and Stem Cell Laboratory is dedicated to understanding how normal stem cells transform into cancer stem cells and to developing targeted therapies that eliminate
-
developing targeted therapies that eliminate these treatment-resistant cells. Cancer stem cells are increasingly recognised as key drivers of tumour growth, relapse, and resistance to conventional therapies